Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fu

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
International Journal of Cardiology|August 8, 2006
Autoimmunity in idiopathic dilated cardiomyopathy: from patients to molecules and back to patientsMichael Fu
Cardiology|August 1, 2008
Autoantibodies in atrial fibrillation: actors, biomarkers or bystanders? How far have we come?Michael Fu
Autoimmunity|September 11, 2008
Autoimmunity and idiopathic dilated cardiomyopathy: where we stand?Michael Fu
International Journal of Cardiology|February 15, 2011
Hypertension in the elderly: where are we?Michael Fu
International Journal of Cardiology|November 3, 2007
Heart failure therapy in the elderly: where are we? What are we doing?Michael Fu
International Journal of Cardiology|November 21, 2007
Beta-blocker therapy in heart failure in the elderlyMichael Fu
European Journal of Heart Failure|January 27, 2009
Inflammation in chronic heart failure: what is familiar, what is unfamiliar?Michael Fu
Autoimmunity|September 11, 2008
Autoantibodies in atrial fibrillation: actor, biomaker or bystander?Akiyasu Baba, Michael Fu
The Keio Journal of Medicine|January 17, 2003
Is cardiomyopathy an autoimmune disease?Michael Fu, Shinobu Matsui
International Journal of Cardiology|July 28, 2006
Pathological importance of anti-G-protein coupled receptor autoantibodiesShinobu Matsui, Michael Fu
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
International Journal of Cardiology|August 8, 2006
Autoimmunity in idiopathic dilated cardiomyopathy: from patients to molecules and back to patientsMichael Fu
Cardiology|August 1, 2008
Autoantibodies in atrial fibrillation: actors, biomarkers or bystanders? How far have we come?Michael Fu
Autoimmunity|September 11, 2008
Autoimmunity and idiopathic dilated cardiomyopathy: where we stand?Michael Fu
International Journal of Cardiology|February 15, 2011
Hypertension in the elderly: where are we?Michael Fu
International Journal of Cardiology|November 3, 2007
Heart failure therapy in the elderly: where are we? What are we doing?Michael Fu
International Journal of Cardiology|November 21, 2007
Beta-blocker therapy in heart failure in the elderlyMichael Fu
European Journal of Heart Failure|January 27, 2009
Inflammation in chronic heart failure: what is familiar, what is unfamiliar?Michael Fu
Autoimmunity|September 11, 2008
Autoantibodies in atrial fibrillation: actor, biomaker or bystander?Akiyasu Baba, Michael Fu
The Keio Journal of Medicine|January 17, 2003
Is cardiomyopathy an autoimmune disease?Michael Fu, Shinobu Matsui
International Journal of Cardiology|July 28, 2006
Pathological importance of anti-G-protein coupled receptor autoantibodiesShinobu Matsui, Michael Fu
Pageof 21